No Continuing Obligations. The parties hereto confirm and agree that upon your termination of employment pursuant to this letter agreement, you shall have no further obligations under the Agreement except as expressly provided in Section 6.1(D) thereof.
No Continuing Obligations. You acknowledge and agree that any landscaping, retaining walls, entry statements and other structures established by us in Lakeside Success Private Estate may not be maintained by us after the actual Settlement Date.
No Continuing Obligations. Except as may be set forth in any of the Leases, neither the Contributor nor any of the Property LLCs is a party to any written contract with any Governmental Entity or any person pursuant to which any Property LLC or the Contributor have any indemnity or other continuing obligation with respect to (i) the remediation or investigation of any condition resulting from the treatment, storage, or release of Hazardous Substances; or (ii) any actual or potential non-compliance with Environmental Laws.
No Continuing Obligations. THIS AGREEMENT IS NOT AN EMPLOYMENT CONTRACT AND NOTHING IN THIS AGREEMENT SHALL BE DEEMED TO CREATE IN ANY WAY WHATSOEVER ANY OBLIGATION ON THE PART OF THE COMPANY TO CONTINUE THE PURCHASER’S EMPLOYMENT WITH THE COMPANY.
No Continuing Obligations. At the time of Closing there will be no leases or other occupancy agreements affecting any of the Transbay Parcel F Property, and no obligations in connection with the Transbay Parcel F Property, including service contracts, utility contracts, maintenance contracts, employment contracts, management contracts, or brokerage and leasing commission agreements, which will be binding upon Buyer after Closing, except as specified in Section 3.2.
No Continuing Obligations. Neurocrine agrees that, upon completion of the Closing and thereafter, Wyeth shall have no further or continuing rights or obligations (a) with respect to the Compound Patent, (b) under the Compound License Agreement, or (c) under the 2002 Consent Agreement, to the extent that any such obligations relate solely to the Compound. Notwithstanding the foregoing, Wyeth agrees that it will at all times remain obligated under the 2002 Consent Agreement as and only to the extent that Wyeth is and remains the owner and licensor (to Neurocrine, DOV or Neurocrine's Approved Sublicensee) of the Wyeth Know-How and Wyeth Patents (as such terms are defined in the Compound License Agreement, but not including the Compound Patent).
No Continuing Obligations. Except as disclosed in Section 3.05 of the Disclosure Schedule or as otherwise provided for herein or in connection with the agreements, instruments and other transactions contemplated hereby, following the Merger there will be no material obligations owing to the Partners by the Partnerships or the Purchasers.
No Continuing Obligations. Upon termination of this Agreement, HealthTrust shall have no further obligations hereunder, including, without limitation, no obligation to maintain, update or advise Participant or its Facilities concerning any Products or Services, except (i) as necessary to support any continuing contracts under Section 3.3, (ii) to receive, process and pay to Participant its allocable portion of any rebates earned prior to termination, and (iii) to provide the applicable reporting for rebates and GPO Fees with respect to Participant purchases from Vendors made prior to termination or for any Custom Agreements that remain in effect after the date of intended termination. HealthTrust shall have no obligation to pay Participant any amounts received by HealthTrust from Vendors more than one (1) year after termination of this Agreement based on purchases by Participant or Facilities under Vendor Contracts. Participant shall remain obligated to pay for all purchases by it and the Facilities made under such Vendor Contracts.
No Continuing Obligations. Neither any Contributor nor, to such Contributor’s knowledge, Venice Ltd., are a party to any contract with any governmental or regulatory authority or any person pursuant to which Venice Ltd. or any of the Contributors have any indemnity or other continuing obligation with respect to (i) the remediation or investigation of any condition resulting from the treatment, storage, or release of Hazardous Substances; or (ii) any actual or potential non-compliance with Environmental Laws.
No Continuing Obligations. Following the closing, Implantable Vision shall be solely responsible for prosecution, maintenance and defense of the patents, patent applications and trademarks that are described as Assets. Implantable Vision shall be solely responsible for pursuit of any further actions with respect to IDE G980278 and any liabilities related to the clinical trial.
